Global Leading Market Research Publisher QYResearch announces the release of its latest report “ESR Analyser – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global ESR Analyser market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for ESR Analyser was estimated to be worth US316millionin2025andisprojectedtoreachUS316millionin2025andisprojectedtoreachUS 423 million, growing at a CAGR of 4.5% from 2026 to 2032.
ESR Analyser is a clinical laboratory instrument that measures the Erythrocyte Sedimentation Rate (ESR), or the speed at which red blood cells settle in anticoagulated blood, typically over one hour. It is used to detect and monitor inflammation, infections, autoimmune diseases, and cancers by analysing how far red blood cells fall in a tube. Modern automated analysers often use infrared technology to provide fast, standardized, and precise results, often in less than 30 minutes. In 2025, the global sales of ESR Analyser are expected to reach 38,600 units, with an average price of USD 8,194 per unit and an industry gross profit margin of approximately 38%.
Globally, the aging population (over 65 years) is rising significantly. Elderly patients often suffer from multiple chronic and inflammatory conditions requiring routine inflammation screening. One of the primary drivers for ESR analysers is the increasing global burden of chronic inflammatory diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), infections (e.g., tuberculosis, endocarditis), and other autoimmune conditions. ESR is a widely used biomarker for assessing inflammation and disease progression in these conditions. Modern laboratories are adopting automated ESR analysers to replace manual Westergren or micro-sedimentation methods, which are labor-intensive and time-consuming.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5510543/esr-analyser
Industry Context: The Role of ESR in Modern Diagnostics
The Erythrocyte Sedimentation Rate (ESR) test remains one of the most widely performed hematological tests in clinical practice, despite being one of the oldest laboratory tests still in use. The test measures the distance that erythrocytes fall in a vertical tube over a specified period—typically one hour—providing an indirect measure of acute-phase protein levels, particularly fibrinogen and immunoglobulins. While non-specific, ESR is valuable as a screening test for inflammation, a prognostic indicator in certain diseases, and a monitoring tool for treatment response. The global burden of chronic inflammatory diseases continues to escalate: rheumatoid arthritis affects approximately 1% of the global population, systemic lupus erythematosus affects an estimated 5 million people worldwide, and autoimmune conditions collectively affect 7-10% of the population in developed countries. This disease burden, combined with aging demographics and the ongoing shift toward automated laboratory workflows, drives sustained demand for ESR analysers.
Market Drivers: Automation and Clinical Demand
Rising Global Burden of Inflammatory Disease. The prevalence of rheumatoid arthritis is estimated at 0.24-1% worldwide, with higher rates in North America and Northern Europe. Systemic lupus erythematosus affects approximately 20-150 per 100,000 individuals. The incidence of inflammatory bowel disease, another condition where ESR is routinely monitored, has increased substantially in newly industrialized regions. These trends, coupled with aging populations in developed economies and increasing diagnostic capacity in emerging markets, support sustained demand for ESR testing.
The Automation Imperative. Manual Westergren and micro-sedimentation methods remain standard in many laboratories globally. However, these methods are labor-intensive, time-consuming, and subject to operator variability. Automated ESR analysers provide standardized results, reduce operator time, integrate with Laboratory Information Systems, and improve workflow efficiency in high-volume settings. The adoption of closed-tube sampling and direct sample processing has significantly reduced laboratory workflow burden and improved occupational safety by minimizing blood exposure.
Technological Advancements. The integration of infrared technology, digital photometry, and image analysis has substantially improved measurement precision and enabled rapid processing. Automated analysers are increasingly capable of handling primary blood collection tubes, reducing handling steps and eliminating manual sample preparation. These innovations have improved both analytical and clinical performance while reducing turnaround time.
Product Segmentation and Regional Dynamics
The market is segmented by sample capacity into big sample numbers and small sample numbers systems. Big sample number analysers are employed in high-volume clinical and reference laboratories, providing automated processing of large test volumes with minimal operator intervention. Small sample number systems serve smaller clinical settings, physician offices, and point-of-care applications.
By application, the market is segmented into Medical Use and Scientific Research. Medical use dominates, driven by routine clinical adoption for screening, diagnosis, and monitoring. Scientific research applications involve specialized study settings requiring ESR measurements.
Regionally, North America and Europe represent mature markets characterized by high automation penetration and stable replacement demand. The Asia-Pacific region, led by China, India, and Southeast Asian nations, exhibits the highest growth potential due to expanding healthcare access, increasing testing volumes, and healthcare infrastructure investments.
Competitive Landscape and Strategic Outlook
Key players include Alifax, Streck, ALCOR Scientific, RR Mechatronics, DIESSE Diagnostica, JOKOH, Sarstedt, ELITechGroup, SFRI, HemaTechnologies, Disera, Mindray, Beijing Succeeder, Perlong, Beijing ZONCI Technology, Shenzhen Yhlo Biotech, Chongqing Tianhai MEDICAL, Caretium Medical Instruments, and Chongqing Nanfang. Competition focuses on automation capabilities, throughput, integration features, and total cost of ownership.
The market is positioned for steady growth through 2032, supported by the convergence of chronic disease burden, aging demographics, and laboratory automation trends. Manufacturers investing in artificial intelligence for patient risk stratification and digital connectivity features will capture disproportionate value.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
